TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions: Advanced Breast Cancer; Treatment-Refractory Solid Tumors; Retinoblastoma Deficiency; SCLC; Soft Tissue Sarcoma; Endometrial Cancer; Bladder Cancer Interventions: Drug: Palbociclib Oral Product; Drug: TAS-116 Sponsors: Brown University; Taiho Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials